Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jindřich Lokaj is active.

Publication


Featured researches published by Jindřich Lokaj.


Parkinsonism & Related Disorders | 2009

Serum inflammatory biomarkers in Parkinson's disease.

Michal Dufek; Markéta Hamanová; Jindřich Lokaj; David Goldemund; Irena Rektorová; Zuzana Michálková; Kateřina Sheardová; Ivan Rektor

Numerous recent findings indicate the involvement of a neuroinflammatory reaction in the neurodegeneration in idiopathic Parkinsons disease (PD). We examined 29 consecutive patients with PD, ages 54-84 years, most of whom were moderately impaired (median UPDRS 19; Hoehn-Yahr 3; MMSE 28). A series of serum biomarkers were investigated, and their levels were correlated with the degree of the motor and cognitive impairment. There were no abnormalities of IL-6, acute phase proteins (C-reactive protein, serum amyloid A, alpha 1-antitrypsin, orosomucoid, ceruloplasmin, alpha 2-macroglobulin, transferrin, prealbumin) and factors of the complement system (C1q, C1-INH, C3, C4). A decrease in Mannan-binding lectin (MBL) levels was observed in six patients; an elevation of tumor necrosis factor-alpha (TNF-alpha) was found in 12 patients. No statistically significant correlation was found between the patients clinical state (neuropsychologic and motor, as expressed by UPDRS III, Hoehn-Yahr, and MMSE) and the immunomarker changes. Our results indicate that the inflammatory process may be reflected in the serum; nevertheless, further research is needed to elucidate the possible clinical implications.


Clinical and Experimental Immunology | 2007

Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients

Vojtěch Thon; Hm. Wolf; M. Sasgary; Jiří Litzman; A. Samstag; I. Hauber; Jindřich Lokaj; M. M. Eibl

CVID is characterized by hypogammaglobulinaemia and impaired antibody production. Previous studies demonstrated defects at the T cell level. In the present study the response of purified CD4+ and CD8+ T lymphocytes to stimulation with anti‐TCR monoclonal antibody (the first signal) in combination with anti‐CD4 or anti‐CD8, anti‐CD2 and anti‐CD28 MoAbs (the costimulatory signals) was investigated. Both CD4+ and CD8+ T cells from the patients showed significantly reduced IL‐2 release following stimulation via TCR and costimulation via CD4 or CD8 and CD2, respectively. However, normal IL‐2 production following TCR plus phorbol myristate acetate (PMA) costimulation and normal expression of an early activation marker, CD69, after TCR + CD28 stimulation indicated that TCR was able to transduce a signal. Furthermore, both IL‐2 and IL‐4 release were impaired in CD4+ lymphocytes following TCR + CD28 stimulation. In addition, stimulation via TCR + CD28 resulted in significantly decreased expression of CD40 ligand in the patients. These results suggest that the integration of activating signals derived from the TCR and costimulatory molecules is defective in CVID patients; the defect is not confined to costimulation via a single molecule, or restricted to cells producing Thl‐type cytokines such as IL‐2, and is expressed in both CD4+ and CD8+T cell subsets.


International Archives of Allergy and Immunology | 2000

IgA Deficiency in Czech Healthy Individuals and Selected Patient Groups

Jiří Litzman; Irena Ševčíková; Dagmar Štikarovská; Zdena Pikulová; Alexandra Pazdírková; Jindřich Lokaj

Background: Selective IgA deficiency (IgAD) is the most common immunoglobulin deficiency with a variety of clinical manifestations. The frequency of IgAD differs depending on the ethnic origin and clinical symptoms of investigated persons. Methods: The prevalence of IgAD (serum IgA level <0.05 g/l) was determined in 5,310 Czech blood donors, 10,326 patients who had undergone immunological investigation, and 246 first-degree relatives of IgAD and common variable immunodeficiency (CVID) patients. Results: IgAD was detected in 13 (1/408; 0.24%) of the blood donors. The prevalence of IgAD was increased both in children (48/3,113; 1.5%) and adults (33/3,824; 0.9%) referred for frequent respiratory tract infections (in both cases p < 0.001) compared to the healthy population. The frequency of IgAD was 12/189 (6%) in first-degree relatives of IgAD patients and 9/57 (16%) in relatives of CVID patients, with the highest frequency observed in children of CVID patients. Conclusions: The prevalence of IgAD in the Czech healthy population is comparable to that in other Caucasians. The frequency is increased in children with recurrent respiratory tract infections and especially in relatives of patients with immunoglobulin deficiencies.


Clinical and Experimental Immunology | 1997

Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired.

Vojtěch Thon; H. Eggenbauer; Hm. Wolf; Mb. Fischer; Jiří Litzman; Jindřich Lokaj; M. M. Eibl

CVID is a primary immunodeficiency syndrome comprising a heterogeneous group of patients with hypogammaglobulinaemia and defective formation of specific antibodies. Previous studies demonstrated defective T cell responsiveness to antigen in a major subgroup of patients. In the present study we investigated the capacity of peripheral blood monocytes and Epstein–Barr virus (EBV)‐transformed B cell lines from seven patients with CVID, including two patients expressing an extended MHC haplotype described to be associated with CVID, to present antigen (Tet. Tox.) to CD4+ antigen‐specific T cell lines from healthy controls. The results presented show an unimpaired capacity of peripheral blood monocytes to present antigen in all patients studied. In addition, the present study demonstrates for the first time that CVID B cells function normally as antigen‐presenting cells (APC). These findings indicate that expression of a certain MHC phenotype in CVID is not associated with a defect in the presentation of recall antigen by monocytes and B cells. Based on these studies, uptake, processing and re‐expression of recall antigen in association with MHC class II molecules on the APC surface are functional and there is no indication for structural abnormalities of the MHC class II molecules expressed by the patients studied that could be essential for their function in antigen binding and presentation.


Clinical and Experimental Immunology | 2006

T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency

Jiří Litzman; Marcela Vlkova; Zdenka Pikulova; Dagmar Štikarovská; Jindřich Lokaj

Selective deficiency of immunoglobulin A (IgAD) and common variable immunodeficiency (CVID) are genetically closely related diseases, both of unknown pathogenesis. A plethora of abnormalities in lymphocyte subpopulations and expression of activation markers were repeatedly documented in CVID patients, while almost no data are available about lymphocyte subpopulations in IgAD patients. We determined basic lymphocyte subpopulations and those subpopulations that were reported to be abnormal in CVID patients (CD25, human leucocyte antigen (HLA)‐DR CD45RA, CD45RO, CD27, CD28 and CD29 on both CD4+ and CD8+ cells, CD57 and CD38 on CD8+ cells, CD21, CD27, IgM, IgD on B lymphocytes) in 85 patients with IgAD, 47 patients with CVID and in 65 healthy controls. Statistical analysis was performed by the Mann–Whitney U‐test; significant P‐values were determined by means of Bonferonis correction. Our results showed an increase in the relative number of CD8+ cells and a decrease in the absolute number of CD4+ cells compared to healthy people, but similar abnormalities in CVID patients were much more expressed. IgAD patients had significantly decreased expression of HLA‐DR and increased expression of CD25 on CD4+ lymphocytes, also CD29 expression was decreased on CD8+ cells, while other activation/differentiation markers on T cells (including the expression of CD45RA and CD45RO antigens) were not changed. There were no statistically significant abnormalities in B lymphocyte developmental stages in IgAD patients compared to healthy controls. Our observation showed that the majority of T and B lymphocyte subpopulation abnormalities described previously in CVID are not present in IgAD patients.


European Journal of Pediatrics | 1999

Isoprinosine does not protect against frequent respiratory tract infections in childhood

Jiří Litzman; Jindřich Lokaj; Marcela Krejčí; Sáva Pešák; Gareth Morgan

Abstract Isoprinosine, an in vitro immuno-enhancing agent principally acting by stimulating T-lymphocytes, is one of a number of agents sometimes used in an attempt to prevent recurrent respiratory infections in children, although there are no formal trials for this particular drug. We performed a placebo-controlled double-blind trial to assess the efficacy of isoprinosine (50 mg/kg per day) for 6 weeks followed by 50 mg/kg per day twice weekly for 6 weeks in the prevention of frequent acute respiratory tract infections in 102 children aged 4–8 years. A total of 43 children treated with isoprinosine and 41 with placebo finished the study. Despite a transient increase in the total number of CD3+, CD4+ and CD8+ T-lymphocytes after 6 weeks of daily isoprinosine treatment, there was no difference in the number and length of duration of acute respiratory infections, number of antibiotic courses and number of days with cough, pharyngitis, rhinitis and increased body temperature (≥37.0°C and ≥38.0°C). There were no changes in markers of T- or B-lymphocyte activation (CD25, HLA-DR, CD45RA/RO, CD23). Conclusion Attempts at immunomodulation using isoprinosine in the dose and for the duration used may increase the total numbers of both CD4 and CD8 T-lymphocytes but is ineffective in prevention of respiratory tract infections in childhood.


Journal of Paediatrics and Child Health | 1998

Agammaglobulinaemia in a girl with a mosaic of ring 18 chromosome

Jiří Litzman; Věra Bryšová; Renata Gaillyová; Vojtěch Thon; A. Pijackova; K. Michalova; Z. Zemanova; Jindřich Lokaj

A patient with a mosaic karyotype 45,XX,‐18/46,XX,dic r(18)/46, XX, r(18) with multiple phenotypic abnormalities and immunodeficiency was presented at the age of 14 years. Immunological investigation revealed markedly decreased IgG, IgA and in two of three evaluations also IgM levels. Although selective IgA deficiency is frequent in patients with a ring chromosome 18, this is the third patient described with decreased levels of other immunoglobulin isotypes. The association of chromosome 18 partial deletions and immunoglobulin abnormalities suggests the presence of an as yet unrecognised gene with a pivotal role for immunoglobulin production on chromosome 18.


Acta Paediatrica | 2007

A concurrent occurrence of cutis laxa, Dandy-Walker syndrome and immunodeficiency in a girl

Jiří Litzman; Hana Bučková; Jiří Ventruba; Alena Holčíková; Pavel Mikyška; Jindřich Lokaj

We report on a 17‐y‐old girl with inherited cutis laxa, immunodeficiency and Dandy‐Walker syndrome. Immunodeficiency manifested itself by decreased and fluctuating levels of IgG, IgA and IgM and intermittent leucopenia causing increased susceptibility to respiratory tract infections. Dandy‐Walker syndrome (agenesis of the cerebellar vermis with a large posterior fossa cyst communicating with an enlarged 4th ventricle) was shown on a CT scan but with the exception of macrocrania, no typical signs or symptoms were observed at the age of 17. Loose hyperextensible skin with pendulous skinfolds as a manifestation of cutis laxa was observed from birth. Anomalies of the right pulmonary artery, abnormal branching of the left arteria subclavia (arteria lusoria) from the left aortic arch and bicuspidal aortic valve were also present.


Journal of Paediatrics and Child Health | 2003

Early manifestation and recognition of C2 complement deficiency in the form of pyogenic infection in infancy

Jiří Litzman; Tomáš Freiberger; Dana Bartoňková; Marcela Vlkova; Vojtěch Thon; Jindřich Lokaj

Objective:  Although frequently asymptomatic, C2 complement component deficiency may lead to severe pyogenic infections or lupus‐like illness. In the present report, we describe infectious manifestations in infancy and childhood in our C2‐deficient patients.


Allergy | 2007

Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion

Vojtěch Thon; P. Harle; J. Scholmerich; Pavel Kuklínek; Jindřich Lokaj; Rh Straub

Background:  Hereditary angioedema (HAE) is successfully treated with danazol, a therapeutic steroid compound. To investigate hormones of the hypothalamic‐pituitary‐adrenal (HPA) and hypothalamic‐pituitary‐gonadal (HPG) axis in patients with HAE with and without danazol.

Collaboration


Dive into the Jindřich Lokaj's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hm. Wolf

University of Vienna

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge